Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

The road to precision oncology

Nature Genetics volume 49, pages 320–321 (2017)Cite this article

Subjects

The ultimate goal of precision medicine is to use population-based molecular, clinical and other data to make individually tailored clinical decisions for patients, although the path to achieving this goal is not entirely clear. A new study shows how knowledge banks of patient data can be used to make individual treatment decisions in acute myeloid leukemia.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The knowledge bank approach.

References

  1. Gerstung, M. et al. Nat. Genet. 49, 332–340 (2017).

    Article  CAS  Google Scholar 

  2. Marx, V. Nature 524, 503–505 (2015).

    Article  CAS  Google Scholar 

  3. Collins, F.S. & Varmus, H. N. Engl. J. Med. 372, 793–795 (2015).

    Article  CAS  Google Scholar 

  4. The Global Alliance for Genomics and Health. Science 352, 1278–1280 (2016).

Download references

Author information

Authors and Affiliations

  1. Andrew V. Biankin is at the Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK.,

    Andrew V Biankin

Authors
  1. Andrew V Biankin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew V Biankin.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biankin, A. The road to precision oncology. Nat Genet 49, 320–321 (2017). https://doi.org/10.1038/ng.3796

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.3796

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research